"Small Cell Lung Cancer Treatment Landscape"
Tuesday, March 18
The treatment landscape for small cell lung cancer (SCLC) is continually evolving, with ongoing research aimed at improving outcomes and finding more effective therapies. The combination of chemotherapy and immunotherapy remains the standard approach, with clinical trials playing a vital role in discovering new options.
Speaker for this month's episode: Carl M. Gay, MD, PhD, Assistant Professor, Department of Thoracic-Head & Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Don't miss this informative conversation!
ATTENDING IN-PERSON?
DATE: Tuesday, March 18
TIME: 5:30 p.m. PT/8:30 p.m. ET
LOCATION: YouTube Live youtube.com/go2foundationfo...